Briacell Therapeutics Corp. (BCTX) Q4 2024 Earnings
BCTX·Reported December 16, 2024·Before market open
Diluted EPS came in at $-32.98, missed the $-0.30 consensus by $32.68.
Diluted EPS
$-32.98missed by $32.68
Consensus: $-0.30
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Briacell Therapeutics Corp.'s Q4 2024 earnings report.
Briacell Therapeutics Corp. (BCTX) reported Q4 2024 earnings on December 16, 2024 before market open.
Briacell Therapeutics Corp. reported diluted EPS of $-32.98 for Q4 2024.
EPS missed the consensus estimate of $-0.30 by $32.68.
You can read the 10-Q periodic report (0001493152-24-050214) directly on SEC EDGAR. The filing index links above go to sec.gov.